The initiation of coverage by Baird with an Outperform rating and a price target of $37 is a positive signal for Alkermes. This suggests that Baird's analysis sees potential upside in the stock, likely due to favorable views on the company's pipeline, market position, or financial health. Such analyst actions often lead to increased investor interest and can drive the stock price up in the short term.